[pubmed] Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Predniso
Posté : 18 août 2020 12:00
Clin Ophthalmol. 2020 Jul 22;14:2051-2056. doi: 10.2147/OPTH.S261259. eCollection 2020.
ABSTRACT
PURPOSE: To evaluate the initial treatment response to low doses of prednisolone, compared with moderate doses, in ocular myasthenia gravis (OMG).
PATIENTS AND METHODS: A retrospective chart review of patients with adult-onset (age ≥15 years old) OMG, who were treated with prednisolone, was conducted. Subjects were divided into two groups according to their prednisolone dosing regimen. The low-dose group was defined as those with an average 12-week cumulative dose of prednisolone
Source: https://pubmed.ncbi.nlm.nih.gov/3280161 ... 0&v=2.11.5